Amarin Proceeding to Phase 3 with AMR101 for Hypertriglyceridemia
July 22, 2008
Read more »
Home
ProSeed Capital
About
Investor Extranet
News Releases
Our Committees
Partners
Portfolio
Team
Advisory Services
Biotech Services
About
Team
Search:
Your Privacy
|
Legal Notes
| info@proseedcapital.com